Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by AE Taylor
A Randomised Dose Escalation Study of Subcutaneous Interleukin 2 With and Without Levamisole in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma
British Journal of Cancer
Cancer Research
Oncology
Related publications
Two Randomised Phase II Trials of Subcutaneous Interleukin-2 and Histamine Dihydrochloride in Patients With Metastatic Renal Cell Carcinoma
British Journal of Cancer
Cancer Research
Oncology
High-Dose Interleukin 2 in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Features
PLoS ONE
Multidisciplinary
Durability of Responses in Patients With Metastatic Renal Cell Carcinoma Treated With High Dose Interleukin-2 (HD IL-2)
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Intravenous Interleukin-2 in Patients Over 65 With Metastatic Renal Carcinoma
British Journal of Cancer
Cancer Research
Oncology
A Feasibility Study of Roquinimex (Linomide) and Alpha Interferon in Patients With Advanced Malignant Melanoma or Renal Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Treatment With Tumour Infiltrating Lymphocytes and Interleukin-2 in Patients With Metastatic Melanoma: A Pilot Study
Biotherapy
Monocytes and Neutrophils as ‘Bad Guys’ for the Outcome of Interleukin-2 With and Without Histamine in Metastatic Renal Cell Carcinoma – Results From a Randomised Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
A Multi-Center Phase II Study of High Dose Interleukin-2 Sequenced With Vemurafenib in Patients With BRAF-V600 Mutation Positive Metastatic Melanoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Sorafenib With Interleukin-2 vs Sorafenib Alone in Metastatic Renal Cell Carcinoma: The ROSORC Trial
British Journal of Cancer
Cancer Research
Oncology
